Yasmin Hasan to Cisplatin
This is a "connection" page, showing publications Yasmin Hasan has written about Cisplatin.
Connection Strength
0.228
-
CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial. Lancet Haematol. 2018 May; 5(5):e190-e200.
Score: 0.124
-
Outcomes for patients with cervical cancer treated with extended-field intensity-modulated radiation therapy and concurrent cisplatin. Int J Gynecol Cancer. 2013 Jan; 23(1):119-25.
Score: 0.086
-
Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2011 Aug 01; 80(5):1436-45.
Score: 0.018